COCRYSTAL PHARMA, INC. Gain (Loss) on Extinguishment of Debt
COCRYSTAL PHARMA, INC. (COCP) reported Gain (Loss) on Extinguishment of Debt of $106.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2020-03-27
- COCRYSTAL PHARMA, INC. gain (loss) on extinguishment of debt for the quarter ending 2018-12-31 was $0.00.
- COCRYSTAL PHARMA, INC. gain (loss) on extinguishment of debt for the quarter ending 2018-09-30 was $0.00.
- COCRYSTAL PHARMA, INC. gain (loss) on extinguishment of debt for the quarter ending 2018-06-30 was $0.00.
- COCRYSTAL PHARMA, INC. gain (loss) on extinguishment of debt for the quarter ending 2018-03-31 was $106.00K.
- COCRYSTAL PHARMA, INC. gain (loss) on extinguishment of debt for fiscal 2018 was $106.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $0.00 derived: sum of 2 quarters · filed 2020-03-27 | $0.00 derived: sum of 3 quarters · filed 2020-03-27 | $106.00K 10-K · filed 2020-03-27 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $106.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $106.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $106.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |